Influence of genistein on c-jun, c-fos and fos-b of ap-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 2, 2013, Pages 205-213

  Jurzak, Magdalena ^a   Adamczyk, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Activator Protein 1 (Ap 1); C Jun; Cfos; Fibroblasts; Fos B.; Genistein; Keloid Fibroblasts; Keratinocytes

Indexed keywords

FREE RADICAL; GENISTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB;

ARTICLE; CELL CULTURE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; KELOID; KERATINOCYTE; ONCOGENE C FOS; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN FIBROBLAST; ULTRAVIOLET RADIATION;

CELL LINE; CELL SURVIVAL; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; KELOID; KERATINOCYTES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1;

EID: 84876699979     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kraszewska O., Nynca A., KamiÒska B., Ciereszko R.: Post. Biol. Kom. 34, 189 (2007) (Polish).
2. M̂ller F.J., Diel P., Zieran O., Hertrampf T., Maab J., Vollemer G.: Toxicol. Lett. 196, 142 (2010).
3. Schleipen B., Hertrampf T., Fritzemeir K.H., Kluxen F.M., Lorenz A., Molzbergen A., Velders M., Diel P.: Carcinogenesis 32, 1675 (2011).
4. Wang T.T.Y., Sathyamoorthy N., Phang J.M.: Carcinogenesis 17, 271 (1996).
5. Constantinou A., Huberman E.: Proc. Soc. Exp. Biol. Med. 208, 109 (1995).
6. Li Z., Li J., Mo B., Hu Ch., Liu H., Qi H., Wang X., Xu J.: Cell. Biol. Toxicol. 24, 401 (2008).
7. Park S-Sh., Kim Y-N., Jean Y.K., Kim Y.A., Kim J.E., Kim H., Kim Ch.W.: Cancer Chemother. Pharmacol. 56, 271 (2005).
8. Sandoval M.J., Cutini P.H., Rauschemberger M.B., Massheimer V.L.: Br. J. Nutr. 104, 171 (2010).
9. Schmidt F., Knobbe Ch.B., Frank B., Wolburg H., Weller M.: Oncol. Rep. 19, 1061 (2008).
10. Guo Y., Wang Sh., Hoot D.R., Clinton S.K.: J. Nutr. Biochem. 18, 408 (2007).
11. Kousidou O.C., Mitropoulou T.N., Roussidis A.E., Kletsas D., Theocharis A.D., Karamanos N.K.: Int. J. Oncol. 26, 1101 (2005).
12. Su S.J., Yeh T.M., Chuang W.J., Ho C.L., Chang K.L., Cheng H.L., Liu H.S., Cheng H.L., Hsu P.Y., Chow N.H.: Biochem. Pharmacol. 69, 307 (2005).
13. Marini H., Bitto A., Altavilla D., Burnett B.P., Polito F., Di Stefano V., Minutoli L., Atteritano M., Levy R.M. et al.: J. Clin. Endocrinol. Metab. 93, 4787 (2008).
14. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y.: Biochem. Biophys. Res. Commun. 157, 183 (1988).
15. Cai Q., Wei H.: Nutr. Cancer 25, 1 (1996).
16. Giles D., Wei H.: Nutr. Cancer 29, 77 (1997).
17. Ibrahim W.H., Habib H.M., Chow C.K., Bruckner G.G.: Int. J. Vitam. Nutr. Res. 78, 217 (2008).
18. Rasche M., Rowland I.R., Magee P.J., Pool-Zobel B.L.: Carcinogenesis 27, 2322 (2006).
19. Kang S., Chung J.H., Lee J.H., Fisher G.J., Wan Y.Sh., Duell E.A., Voorhees J.J.: J. Invest. Dermatol.: 120, 835 (2003).
20. Privat M., Aubel C., Arnould S., Communal Y., Ferrara M., Bignon Y.J.: Anticancer Res. 30, 2049 (2010).
21. Shaulian E.: Cell Signal. 22, 894 (2010).
22. Steinmuller L., Cibelli G., Moll J.R., Vinson C., Thiel G.: Biochem. J. 360, 599 (2001).
23. Shaulian E., Karin M.: Oncogene 20, 2390 (2001).
24. Angen P., Szabowski A., Schorpp-Kistner M.: Oncogene 20, 2413 (2001).
25. Rorke E.A., Adhikary G., Jans R., Crish J.F., Eckert R.L.: Oncogene 29, 5873 (2010).
26. Mehic D., Bakiri L., Ghannadan M., Wagner E.F., Tschachler E.: J. Invest. Dermatol. 124, 212 (2005).
27. Lohman F., Gibbs S., Fischer D.: Oncogene 14, 1623 (1997).
28. Mils V., Piette J., Barette C.: Oncogene 14, 1555 (1997).
29. Chen Ch-L., Lion Sh-F., Chen S-J., Shin M-F.: Regul. Toxicol. Pharmacol. 60, 112 (2011).
30. Fisher G.J., Quan T., Purohit T., Shao Y., Cho M.K., He T., Varani J., Kang S., Voorvees J.J.: Am. J. Pathol. 174, 101 (2009).
31. Bernstein L.R., Colburn N.H.: Science 244 (4904), 566 (1989).
32. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., Colburn N. Proc. Natl. Acad. Sci. USA 96, 9827 (1999).
33. Zenz R., Wagner E.F.: Int. J. Biochem. Cell. Biol. 38, 1043 (2006).
34. Huang Z., Hung C., Lin Y., Fang J.: Int. J. Pharm. 364, 36 (2008).
35. Wei H., Cai Q., Rahn R.O.: Carcinogenesis 17, 73 (1996).
36. Miyazaki K., Hanamizu T., Lizuka R., Chiba K.: Skin Pharmacol. Appl. Skin Physiol. 15, 175 (2002).
37. Wei H., Saladi R., Lu Y., Wang Y., Palep S.R., Moore J., Phelps R., Shyong E., Lebwohl M.G.: J. Nutr. 133, 3811 (2003).
38. Wang Y., Yaping E., Zhang X., Lebwohl M., DeLeo V., Wei H.: Carcinogenesis 19, 649 (1998).
39. Rittie L., Fisher G.L.: Aging Res. Rev. 1, 705 (2002).
40. Bran G.M., Goessler U.R., Hormann K., Riedel F., Sadick H.: Int. J. Mol. Med. 24, 283 (2009).
41. Khoo Y.T., Ong Ch.T., Mukhopadhyay A., Han H.Ch., Do D.V., Lim I.J., Phan T.T.: J. Cell. Physiol. 208, 336 (2006).
42. Kim Ch.W., Suh S., Sung S.H., Lee I.K., Lee K.S.: J. Dermatol. Sci. 37, 49 (2005).
43. Teofoli P., Barduagni S., Ribuffo M., Campanella A., De Pitaí O., Puddu P.: J. Dermatol. Sci. 22, 31 (1999).
44. Stephenson FH. Calculation for molecular biology and biotechnology: A guide to mathematics in laboratory. p. 211, Academic Press, Esevier, London 2010.
45. Tyburski J., Studziska A., Daca P., Tretyn A.: Biotechnologia 1 (80), 86 (2008) (Polish).
46. Romanowski T., Markiewicz A., Bednarz N., Bielawski K.P.: Postepy Hig. Med. Dosw. 61, 500 (2007) (Polish).